“…No difference in intact mechanical thresholds but higher after nerve injury, returned to intact values by day 7 (Bacon et al, 2007;Hulse et al, 2011) Reduction in acetone-induced pain-like behavior after PSNI (Hulse et al, 2012) Lower levels of cell death in vivo and in vitro (Elliott-Hunt et al, 2004) Decrease in opiate withdrawal behavior Galanin (inducible) (Pope et al, 2010)/tTA under control of 20 kb murine genomic galanin, 4.6 kb murine genomic galanin under control of tetO/CBA/BL6 F1 hybrid Increased mechanical thresholds after nerve injury reduced by galanin suppression (Pope et al, 2010) Growth hormone (Perumal and Vrontakis, 2003)/320 bp rat GH promoter driving full-length rat preprogalanin cDNA including poly A tail (4.5 kb transgene)/C57BL6/SJL F2 Â Swiss CD Increased serum levels of galanin, prolactin and GH (GH in males only) Pituitary hyperplasia and adenomas in older mice (Perumal and Vrontakis, 2003) Reduced CPZ-induced myelin breakdown (Zhang et al, 2012) Platelet-derived growth factor driving galanin (Holmberg et al, 2005a)/1.3 kb PDGF-b with galanin/GMAP gene construct, including intron 2 of the mouse galanin gene (genomic DNA and cDNA)/CBA/BL6 F1 hybrid Increase in learned helplessness in old mice (Pirondi et al, 2005b). Increase in learned helplessness (Kuteeva et al, 2005) Reduced neuronal loss postaxotomy, 35% reduction in plasma extravasation, increased response in phase 2 of formalin test (Holmberg et al, 2005a) Elevated thermal thresholds but no difference in mechanical thresholds or cold thermal in intact adults (Blakeman et al, 2001) Decreased response to evoked seizures (Kokaia et al, 2001) Delayed reduction in NA after intracerebroventricular injection of galanin to ventral hippocampus.…”